Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 02, 2024

BUY
$14.18 - $22.31 $267,619 - $421,056
18,873 Added 103.59%
37,092 $798,000
Q3 2023

Nov 01, 2023

BUY
$18.22 - $25.85 $104,728 - $148,585
5,748 Added 46.09%
18,219 $350,000
Q2 2023

Aug 04, 2023

BUY
$22.62 - $39.32 $52,387 - $91,065
2,316 Added 22.81%
12,471 $317,000
Q1 2023

Apr 27, 2023

BUY
$30.17 - $41.11 $205,759 - $280,370
6,820 Added 204.5%
10,155 $367,000
Q4 2022

Feb 02, 2023

SELL
$36.43 - $49.4 $483,207 - $655,241
-13,264 Reduced 79.91%
3,335 $132,000
Q3 2022

Nov 04, 2022

BUY
$40.66 - $53.03 $674,915 - $880,244
16,599 New
16,599 $773,000
Q3 2021

Oct 28, 2021

SELL
$101.99 - $166.36 $19,276 - $31,442
-189 Reduced 2.88%
6,365 $1.06 Million
Q2 2021

Aug 12, 2021

BUY
$141.6 - $179.06 $765,914 - $968,535
5,409 Added 472.4%
6,554 $1.09 Million
Q1 2021

Apr 26, 2021

BUY
$132.81 - $182.18 $152,067 - $208,596
1,145 New
1,145 $159,000
Q4 2019

Feb 05, 2020

SELL
$76.41 - $117.54 $141,282 - $217,331
-1,849 Closed
0 $0
Q3 2019

Oct 15, 2019

SELL
$61.52 - $91.1 $286,621 - $424,434
-4,659 Reduced 71.59%
1,849 $158,000
Q2 2019

Jul 26, 2019

BUY
$58.04 - $66.99 $187,120 - $215,975
3,224 Added 98.17%
6,508 $421,000
Q1 2019

Apr 18, 2019

SELL
$35.52 - $62.62 $131,317 - $231,506
-3,697 Reduced 52.96%
3,284 $0
Q4 2018

Jan 16, 2019

BUY
$35.43 - $56.29 $247,336 - $392,960
6,981 New
6,981 $271,000
Q2 2018

Jul 30, 2018

SELL
$72.38 - $92.5 $83,237 - $106,375
-1,150 Closed
0 $0
Q1 2018

Apr 26, 2018

BUY
$69.46 - $88.57 $77,100 - $98,312
1,110 Added 2775.0%
1,150 $99,000
Q4 2017

Jan 10, 2018

BUY
$65.94 - $93.31 $2,637 - $3,732
40
40 $2,000

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $133M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.